Abstract. We used a reverse transcription-polymerase chain reaction (RT-PCR) to obtain the genotypes of circulating hepatitis C virus (HCV) in patients from a Gastro-Hepatology Unit in the city of Salvador (Bahia State) in northeastern Brazil. Viral RNA was detected in 83 (65.4%) of 127 anti-HCV seropositive serum samples. Positivity was significantly associated with alterations in levels of aspartate aminotransferase and alanine aminotransferase (P Ͻ 0.05). Genotyping of HCV was performed by RT-PCR using genotype-specific primers from the core region: 24.1% were infected with subtype 1a, 38.6% with 1b, 3.6% with 2, 21.7% with 3a, and 12.0% with a mixed genotype. There was no difference in genotype distribution when compared with results from other Brazilian locations. Surprisingly, the high frequency of genotype 3 in Brazilian samples continues to be different from that reported around the world and warrants further investigation. Hepatitis C virus (HCV), a recently discovered virus of low viremia and immunogenicity, is unique among viruses infecting human beings in that the detection of viral RNA remains the most sensitive and reliable means of confirming infection. In addition, variations in nucleotide sequences are used to determine genotypes. [1] [2] [3] [4] [5] [6] [7] Since the discovery of HCV by Choo and others, 8 more than 80 genotypes have been identified. The sequences of the subgenomic regions of these genotypes differ by more than 20%. 7 The classification of HCV genotypes by Simmonds and others 7 groups HCV isolates by a phylogenetic analysis of sequence variation in part of a 222-basepair (bp) of a region coding for the nonstructural protein NS5b. They found 2 different tiers of sequence variation within this region and classified HCV into 6 types designated by Arabic numbers (1, 2, 3, etc.) and further divided into subtypes designated by letters (a, b, c, etc.). The distribution of HCV genotypes has been found to vary geographically. 9 Genotypes 1, 2, and 3 and their subtypes are distributed worldwide. In contrast, genotype 4 appears to be a pan-African type (the principal genotype in Zaire and Egypt), and genotype 5 has been found to be the principal genotype in South Africa.
Hepatitis C virus (HCV), a recently discovered virus of low viremia and immunogenicity, is unique among viruses infecting human beings in that the detection of viral RNA remains the most sensitive and reliable means of confirming infection. In addition, variations in nucleotide sequences are used to determine genotypes. [1] [2] [3] [4] [5] [6] [7] Since the discovery of HCV by Choo and others, 8 more than 80 genotypes have been identified. The sequences of the subgenomic regions of these genotypes differ by more than 20%. 7 The classification of HCV genotypes by Simmonds and others 7 groups HCV isolates by a phylogenetic analysis of sequence variation in part of a 222-basepair (bp) of a region coding for the nonstructural protein NS5b. They found 2 different tiers of sequence variation within this region and classified HCV into 6 types designated by Arabic numbers (1, 2, 3, etc.) and further divided into subtypes designated by letters (a, b, c, etc.). The distribution of HCV genotypes has been found to vary geographically. 9 Genotypes 1, 2, and 3 and their subtypes are distributed worldwide. In contrast, genotype 4 appears to be a pan-African type (the principal genotype in Zaire and Egypt), and genotype 5 has been found to be the principal genotype in South Africa.
10,11 Genotype 6 and its variants have been found mainly in Asia. 1, 9, 12 In Brazil, recent studies performed in the southeastern (States of São Paulo and Rio de Janeiro) and southern (State of Rio Grande do Sul) regions demonstrated the presence of 3 HCV genotypes (1, 2, and 3). [13] [14] [15] [16] Studies suggest that the clinical features of liver disease depend on HCV genotypes. [17] [18] [19] [20] For instance, an association between certain genotypes and disease severity, liver cirrhosis, and primary liver cancer has been reported. 19 It is also noteworthy that the success of interferon treatment seems to be type or subtype related. 21 These observations make the identification of infecting HCV genotypes from different geographic regions of great interest.
The primary objective of the present study was to detect and determine the genotypes of circulating HCV isolates in northeastern Brazil. The relationship between HCV RNA positivity and alterations in levels of aspartate aminotransferase (AST) or alanine aminotransferase (ALT) was determined.
MATERIALS AND METHODS
Samples. Sera were collected from 127 repeatedly anti-HCV seropositive subjects (age range ϭ 13-75 years; male: female ratio ϭ 98:29) who consecutively attended the Gastro-Hepatology Unit of the University Hospital of Bahia between May and September 1997. Serology was performed using a third-generation enzyme immune assay (EIA) (HCV EIA III; Abbott Laboratories, North Chicago, IL). None of the subjects were drug addicts. All samples were aliquoted within 2 hr and stored immediately at Ϫ70ЊC until use. Aliquots were not thawed more than once prior to analysis. A complete follow-up of AST and ALT levels (Dimension RxL; Dade Behring, Newark, DE) over a 6-month period was obtained for 65 subjects. The AST and ALT levels were routinely determined at 3 points and were found to be within normal ranges (12-37 U/L for AST and 30-65 U/L for ALT) or altered. This project was approved by the Institution Ethical Committee and informed consent was obtained from each subject.
Extraction of HCV RNA and cDNA synthesis. Two hundred microliters of serum were used for HCV RNA extraction by the guanidinium isothiocyanate-phenol-chloroform method 22 and then precipitated with ethanol and dried. 23 The HCV RNA was immediately doubly transcribed into cDNA using the antisense primers NC4 (ACT CGC AAG CAC CCT ATC AGG CAG TAC) from the 5Ј non-coded region (5ЈNCR) and 186 NTER (ATA GAG AAA GAG CAA CCG GG) from the core region.
Detection of HCV RNA. A combined reverse transcription-polymerase chain reaction (RT-PCR) was used in 2 different experiments to amplify cDNA from each sample and from positive and negative controls. For standardization of the HCV RNA detection system, 35 samples were tested blindly. These were 12 positive controls with known concentration of HCV (as determined in the Quantiplex HCV RNA 2.0 assay; Chiron Corp., Emeryville, CA) and 23 negative controls. Negative controls consisted of samples from normal individuals and from patients infected by other viral agents, such as hepatitis A virus and hepatitis B virus. All negative controls were found to be repeatedly anti-HCV negative and HCV RNA negative. The PCR was carried out FIGURE 1. Electrophoresis of hepatitis C virus polymerase chain reaction (PCR) products (pattern of reaction in the second-round genotyping PCR). The specificity was checked by the ability of the primers to amplify DNA with predicted length, using cDNAs for genotypes 1a, 1b, 2, 3a, and 4, which had been determined by mixed primers located in the core region, as described by Lerat and others. 25 Lane 1, molecular weight marker; lane 2, blank control; lanes 3-7, genotype-specific products. bp ϭ basepairs. with the sense primer NC3 (CCT GTG AGG AAC TAC TGT CTT CAC GCA) and the antisense primer NC4 for 45 cycles (94ЊC for 45 sec, 64ЊC for 45 sec, and 72ЊC for 1 min). 24 Positivity was initially established by electrophoresis on a 3% agarose gel and staining the gel with ethidium bromide. The size of the RT-PCR product was 268 bp. Southern blotting. The identification of the amplified product as coded for HCV-derived HCV-cDNA was confirmed by Southern blotting with probe A89 (CCA TAG TGG TCT GCG GAA CCG GTG AGT ACA) labeled with biotin or 32 P. Samples that were negative by staining with ethidium bromide, but positive in the Southern blot were retested.
Genotyping of HCV. This was accomplished by means of a nested PCR assay that uses primers located in the core region and amplifies genotype-specific sequences. 25 Briefly, a first PCR (5 l of RNA, total ϭ 50 l) was carried out with the sense primer 256 (CGC GCG ACT AGG AAG ACT TC), and the antisense primer 186 NTER for 40 cycles (94ЊC for 1 min, 55ЊC for 1.5 min, and 72ЊC for 2 min). These oligonucleotides were used as generic primers capable of amplifying cDNA of all HCV genotypes because their sequences seem to be well conserved in ubiquitous isolates. The amplified product (1 l) was subjected to a second PCR (total ϭ 50 l) using combinations of 10 primers specific for 4 different HCV genotypes: 1 (a and b), 2, 3 (a), and 4. Four sense primers, 104 (AGG AAG ACT TCC GAG CGG TC), 104 IIa (AGG AAG ACT TCG GAG CGG TC), 104 IIIa (CGT AAA ACT TCT GAA CGG TC), and 104 IVa (CGA AAG ACT TCG GAG CGG TC); and 6 antisense primers, 132 Nbis (GCA GCC CTC ATT GCC ATA), 133 Nbis (GCC ATC CTG CCC ACC CCA TG), 134 Nbis1 (ACT TGC CAG TGG AGC GCC G), 134 Nbis2 (ATT TGC CAG TGG AGC GCC G), 339 Nbis (GCT GAG CCC AGG ACC GGC CT), and 465 (TCC CGT CCT CCA CAG CCC TG), were used. Thirty-five cycles were performed at 94ЊC for 1 min, 63ЊC for 1 min, and 72ЊC for 1.5 min. Primers combinations, expected size of products, and corresponding detected genotypes/subtypes were as follows: 104/132Nbis, 125 bp, 1a; 104/133Nbis, 141 bp, 1b; 1041IIa/134Nbisl-2, 75 bp, 2; 104IIIa/339Nbis, 87 bp, 3a; and 104IVa/465 and 336 bp, 4a. The products from second-round genotyping PCR were analyzed by electrophoresis on a 3% agarose gel and stained with ethidium bromide. Figure 1 shows the band pattern consistently produced by the PCR with the genotypespecific primers.
RESULTS
Hepatitis C virus RNA was detected in 83 (65.4%) of 127 samples examined. All results were confirmed with biotin and 32 P-labeled probes. None of the samples were PCR-positive, Southern blot-negative by either of the different hybridization methods, although detection with radioactive probes was at least 10 times more sensitive than with biotin probes. There was no statistically significant association between HCV RNA positivity and either mildly altered (fluctuating) or persistently elevated levels of transaminases. However, HCV RNA positivity was significantly associated with abnormal AST and ALT levels in patients during a 6-month follow-up (P ϭ 0.001 and P ϭ 0.03, respectively) ( Table 1 ).
All HCV RNA-positive samples were typeable as 1a, 1b, 2, 3a, or mixed genotype (Table 2) . No statistically significant correlation of HCV types with age or gender was found.
DISCUSSION
The detection of HCV infection in this study was based on amplification by RT-PCR of fragments from the 5ЈNCR, the most conserved region in the HCV genome. 24, [26] [27] [28] Hepatitis C virus RNA was detected in 65.4% (83 of 127) of the samples and was shown to be significantly associated with AST and ALT levels. These data confirm that active HCV infection develops in a large proportion of anti-HCV-positive subjects and provide further evidence to support its association with changes in AST or ALT levels during the course of infection. 29, 30 However, HCV RNA was also detected in some subjects with AST and ALT levels that were persistently normal. This constitutes a well-known virologic/biochemical dissociation in chronic HCV infection.
Despite optimization of the RT-PCR to detect HCV RNA in serum (the lower limit of detection was approximately 0.2 ϫ 10 Ϫ6 HCV RNA molecules/ml), 34.6% (44 of 127) of the serum samples of the anti-HCV-positive individuals were continuously HCV RNA negative. Fifteen subjects had a complete follow-up for serum AST and ALT levels. Seven (46.7%) had no biochemical abnormalities, while 8 had fluctuations in the levels of these transaminases. However, positivity for HCV RNA cannot be excluded by the methodology used herein. Indeed, recent studies have suggested that detection of HCV RNA in serum or plasma is underestimated, and the use of other specimens, including whole blood and liver tissue, has been recommended to increase the sensitivity of detection of HCV RNA. 31, 32 On the other hand, one cannot exclude the possibility of false-positive anti-HCV EIA results during screening. In addition, some subjects may represent cases of complete resolution of infection. Alternatively, the possibility of a latent infection, with very low viral replication, has been suggested by the disappearance in acute HCV infection of HCV RNA from serum, with subsequent reappearance. 33 For HCV genotyping, an assay 25 adapted from the original technique of Okamoto and others, 5, 34 which uses type-specific primers located in the core region for amplification of genotype-specific sequences, was used. This is the first time that an RT-PCR was used to detect HCV infection in the State of Bahia, Brazil. There was no difference in the genotype distribution compared with studies in other Brazilian locations. [13] [14] [15] [16] Various HCV types, particularly 1 and 3, were equally distributed by age and gender. This apparent homogeneity may represent a peculiarity of the studied population. However, larger series of patients should be studied to ascertain this possibility.
Genotype 1 was the most prevalent (62.7%), followed by genotype 3 (21.7%), with few genotype 2 isolates (3.6%). Subtypes 1b, 1a, and 3a were predominant, with prevalences of 38.6%, 24.1%, and 21.7%, respectively, whereas subtype 2a/2b was rarely found (3.6%) in the studied population. The high prevalence of genotypes 1 and 3 in Brazil is different from what is observed in the United States, Europe, and Japan, where genotypes 1 and 2 are the most frequent. 35 In particular, genotype 3 has a high prevalence among intravenous drug users in Europe. 2, 36 In the population studied herein there were no drug addicts; however, genotype 3 occurred in a high frequency. The absence of genotype 4 in our samples indicates that it is absent or rarely present in our population. Since many people in Bahia are of African descent, this may suggest that either HCV infection is relatively recent or that genotype 4 infections have been supplanted by infections by other genotypes. Ten samples had a mixed pattern, 9 of subtypes 1a/3a and 1 of 1a/1b. Mutations in the core region or co-infection may explain these findings.
Direct sequencing analysis will be used to enable the identification of possible novel subtypes in future studies. Finally, the demonstration that HCV genotype distribution in Brazil is relatively homogeneous should facilitate Public Health surveillance policies. Further investigation is needed to understand the epidemiologic relevance of genotype 3 of HCV, unrelated to drug addiction, described in this paper.
